Mission
ICER's mission is to lead innovation in comparative effectiveness research through methods that integrate considerations of clinical benefit and economic value. Through a unique collaboration with patients, clinicians, manufacturers, insurers and other healthcare stakeholders, ICER develops tools to support patient decisions and medical policy that share the goal of achieving maximum value for every healthcare dollar.
| ICER's appraisal of active surveillance in prostate cancer published in JAMA |
|
In the December 1, 2010 issue of the Journal of the American Medical Association, Dr. Julia Hayes, an affilate researcher at ICER, and colleagues published "Active surveillance compared with initial treatment for men with low-risk prostate cancer: a decision analysis." The paper garnered significant media coverage, including articles in: |